Company Description
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.
It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories.
The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers.
Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
| Country | United States |
| Founded | 1952 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 8,030 |
| CEO | Norman Schwartz |
Contact Details
Address: 1000 Alfred Nobel Drive Hercules, California 94547 United States | |
| Phone | 510 724 7000 |
| Website | bio-rad.com |
Stock Details
| Ticker Symbol | BIO |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000012208 |
| CUSIP Number | 090572207 |
| ISIN Number | US0905722072 |
| Employer ID | 94-1381833 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Norman D. Schwartz | Chairman and Chief Executive Officer |
| Jonathan P. DiVincenzo | President and Chief Operating Officer |
| Tania DeVilliers | Senior Director, Corporate Controller and Interim Principal Accounting Officer |
| Yong Chung | Vice President of Investor Relations |
| Matthew Werner | Senior Vice President and Chief Compliance and Privacy Officer |
| Courtney C. Enloe | Executive Vice President, General Counsel and Secretary |
| Colleen Corey | Executive Vice President of Global Human Resources |
| Michael Crowley | Executive Vice President of Global Commercial Operations |
| Lee Boyd | Senior Vice President of Global Commercial Operations - Asia Pacific |
| James J. Barry | Executive Vice President and President of Life Science Group |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | 144 | Filing |
| Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 31, 2024 | 10-Q | Quarterly Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 22, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 10, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |